What is PSMA-positive metastatic prostate cancer?

• Metastatic castration-resistant prostate cancer (mCRPC) is a type of prostate cancer that has spread to other parts of your body and is no longer responding to hormone treatment that lowers testosterone

• PSMA (prostate-specific membrane antigen) is a biomarker that sits on the outside of prostate cancer cells and is detected by a PSMA positron emission tomography (PET) scan

If your prostate cancer cells have an abundance of PSMA, it means your mCRPC is PSMA positive (PSMA+). PSMA+ cancer cells can be targeted with PLUVICTO.

Noncancerous PSMA+ cells and other surrounding cells will also be impacted.

You can find out if your prostate cancer is PSMA+ by having a PSMA PET scan 

Ask your doctor about treating your metastatic prostate cancer with PLUVICTO.

Next: How PLUVICTO Works >